Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000365764

Medchemexpress LLC Sunitinib | 557795-19-4 | MFCD09260778 | 99.04% | 398.5 g/mol | 200 MG
SDP

Supplier:  Medchemexpress LLC 200MGHY10255A

Encompass_Preferred

Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor and a small-molecule member of pyrroles and monocarboxylic acid amides. It acts as an antineoplastic agent, an angiogenesis inhibitor, and an immunomodulator. This ATP-competitive inhibitor effectively blocks autophosphorylation of Ire1α, preventing consequent RNase activation.

  • Targets VEGFR2 with an IC50 of 80 nM
  • Targets PDGFRβ with an IC50 of 2 nM
  • Inhibits EC 2.7.10.1 (receptor protein-tyrosine kinase)
  • Functions as a neuroprotective agent
  • Acts as a vascular endothelial growth factor receptor antagonist
  • Approved for treating renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST)
  • Approved for adjuvant treatment of recurrent RCC and pancreatic neuroendocrine tumors (pNET)

Catalog No. 50-003-65764


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.